AT336779B - Verfahren zur herstellung einer intravenos vertraglichen vaccine gegen staupe und hepatitis contagiosa canis - Google Patents

Verfahren zur herstellung einer intravenos vertraglichen vaccine gegen staupe und hepatitis contagiosa canis

Info

Publication number
AT336779B
AT336779B AT459273A AT459273A AT336779B AT 336779 B AT336779 B AT 336779B AT 459273 A AT459273 A AT 459273A AT 459273 A AT459273 A AT 459273A AT 336779 B AT336779 B AT 336779B
Authority
AT
Austria
Prior art keywords
intravenos
contagiosa
contractual
canis
hepatitis
Prior art date
Application number
AT459273A
Other languages
English (en)
Other versions
ATA459273A (de
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of ATA459273A publication Critical patent/ATA459273A/de
Application granted granted Critical
Publication of AT336779B publication Critical patent/AT336779B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/175—Canine distemper virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G10—MUSICAL INSTRUMENTS; ACOUSTICS
    • G10L—SPEECH ANALYSIS TECHNIQUES OR SPEECH SYNTHESIS; SPEECH RECOGNITION; SPEECH OR VOICE PROCESSING TECHNIQUES; SPEECH OR AUDIO CODING OR DECODING
    • G10L15/00—Speech recognition
    • G10L15/22—Procedures used during a speech recognition process, e.g. man-machine dialogue
    • G10L2015/226—Procedures used during a speech recognition process, e.g. man-machine dialogue using non-speech characteristics
    • G10L2015/227—Procedures used during a speech recognition process, e.g. man-machine dialogue using non-speech characteristics of the speaker; Human-factor methodology
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT459273A 1972-05-26 1973-05-25 Verfahren zur herstellung einer intravenos vertraglichen vaccine gegen staupe und hepatitis contagiosa canis AT336779B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2225548A DE2225548C3 (de) 1972-05-26 1972-05-26 Intravenös verträglicher Impfstoff gegen Staupe- und Hepatite contagiosa canis

Publications (2)

Publication Number Publication Date
ATA459273A ATA459273A (de) 1976-09-15
AT336779B true AT336779B (de) 1977-05-25

Family

ID=5845894

Family Applications (1)

Application Number Title Priority Date Filing Date
AT459273A AT336779B (de) 1972-05-26 1973-05-25 Verfahren zur herstellung einer intravenos vertraglichen vaccine gegen staupe und hepatitis contagiosa canis

Country Status (13)

Country Link
US (1) US3886270A (de)
AR (1) AR201193A1 (de)
AT (1) AT336779B (de)
AU (1) AU467451B2 (de)
BE (1) BE800132A (de)
CA (1) CA1020461A (de)
DE (1) DE2225548C3 (de)
DK (1) DK141055C (de)
FR (1) FR2189023B1 (de)
GB (1) GB1437006A (de)
NL (1) NL163428C (de)
SE (1) SE7608007L (de)
ZA (1) ZA733571B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL133476B1 (en) * 1981-06-10 1985-06-29 Akad Medyczna Method of obtaining pure antigen hba from human serum
US4990367A (en) * 1987-03-09 1991-02-05 Diamond Scientific Company Canine distemper virus vaccine
US5000951A (en) * 1987-03-09 1991-03-19 Diamond Scientific Company Multivalent canine distemper virus vaccine
CN105884889A (zh) * 2016-04-18 2016-08-24 内蒙古神元生物工程股份有限公司 犬瘟热-传染性肝炎-细小病毒三联卵黄抗体及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470294A (en) * 1961-06-21 1969-09-30 Behringwerke Ag Vaccine for immunization of dogs and foxes against distemper,hepatitis contagiosa and leptospirosis and process for preparing it
US3316153A (en) * 1965-03-29 1967-04-25 Lilly Co Eli Virus purification
US3519400A (en) * 1967-01-25 1970-07-07 Atomic Energy Commission Method of centrifugal separation and recovery of chemical species utilizing a liquid medium

Also Published As

Publication number Publication date
AR201193A1 (es) 1975-02-21
DK141055C (da) 1980-06-23
ZA733571B (en) 1974-04-24
NL163428B (nl) 1980-04-15
DE2225548C3 (de) 1980-05-29
NL163428C (nl) 1980-09-15
BE800132A (fr) 1973-11-28
CA1020461A (en) 1977-11-08
FR2189023A1 (de) 1974-01-25
US3886270A (en) 1975-05-27
AU467451B2 (en) 1975-12-04
DK141055B (da) 1979-12-31
AU5612573A (en) 1974-11-28
DE2225548B2 (de) 1979-09-06
DE2225548A1 (de) 1973-12-06
ATA459273A (de) 1976-09-15
NL7306986A (de) 1973-11-28
GB1437006A (en) 1976-05-26
FR2189023B1 (de) 1976-12-03
SE7608007L (sv) 1976-07-13

Similar Documents

Publication Publication Date Title
AT345654B (de) Futtermittel und verfahren zur herstellung desselben
ATA186276A (de) Verfahren zur herstellung einer hepatitis- virus-vakzine
AT284605B (de) Verfahren zur Herstellung einer Gelierhilfe
AT351526B (de) Verfahren zur herstellung von 4-niederalkyl-5- cyano-oxazolen
AT336779B (de) Verfahren zur herstellung einer intravenos vertraglichen vaccine gegen staupe und hepatitis contagiosa canis
CH437942A (de) Flanschverbindung und Verfahren zur Herstellung der Flanschverbindung
AT341538B (de) Verfahren zur herstellung von glycidylmethacrylat
CH534998A (de) Verfahren und Vorrichtung zur Herstellung einer elektrischen Heizmatte
AT265517B (de) Verfahren zur Herstellung einer Vaccine gegen Staupe
AT342183B (de) Pillingarme polyesterfasern und verfahren zur herstellung derselben
AT334524B (de) Verfahren zur herstellung einer virus-untereinheiten-vaccine
AT335754B (de) Vakuum-formbarer schichtstoff und verfahren zu dessen herstellung
AT312665B (de) Verfahren zur Herstellung einer Unterfahrung
AT336221B (de) Heizkorper und verfahren zur herstellung desselben
AT330345B (de) Verfahren zur herstellung einer insulinzubereitung
DD130935A5 (de) Verfahren zur herstellung von propionsaeureestern
AT328617B (de) Verfahren zur herstellung einer vaccine
AT346516B (de) Verfahren und vorrichtung zur herstellung einer mehrfach-verglasungseinheit
PT64922A (de) Azabicycloalkane und verfahren zu ihrer herstellung
AT286497B (de) Verfahren zur Herstellung einer Vaccine
AT324088B (de) Verfahren zur herstellung von doppelwandigen rohren
AT312664B (de) Verfahren zur Herstellung einer Unterfahrung
AT281280B (de) Verfahren zur Herstellung einer Masern-Vaccine
AT278183B (de) Indirekt heizbare Kathode und Verfahren zur Herstellung einer derartigen Kathode
AT349159B (de) Verfahren zur herstellung neuer bufadienolid- und bufatrienolidaether

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee